Dr Tim Oldham, AdAlta’s CEO and Managing Director, spoke to Proactive Investors about the recent news of the completion of enrolment of healthy volunteers for the AD-214 Phase I extension Study. Watch here:
Dr Tim Oldham, AdAlta’s CEO and Managing Director, spoke to Proactive Investors about the recent news of the completion of enrolment of healthy volunteers for the AD-214 Phase I extension Study. Watch here: